In vitro hematopoietic and endothelial potential of flk-1−/− embryonic stem cells and embryos
- Departments of *Medicine, †Medical Biophysics, and the ‡Institute of Medical Science, University of Toronto, 1 King’s College Circle, Toronto, Ontario, Canada M5G 2C4, and ¶Department of Pathology, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8118, St. Louis, MO 63110
-
Communicated by Phillippa Marrack, National Jewish Medical and Research Center, Denver, CO (received for review November 5, 1998)
Abstract
Mice deficient in the Flk-1 receptor tyrosine kinase are known to die in utero because of defective vascular and hematopoietic development. Here, we show that flk-1 −/− embryonic stem cells are nevertheless able to differentiate into hematopoietic and endothelial cells in vitro, although they give rise to a greatly reduced number of blast colonies, a measure of hemangioblast potential. Furthermore, normal numbers of hematopoietic progenitors are found in 7.5-day postcoitum flk-1 −/− embryos, even though 8.5-day postcoitum flk-1 −/− embryos are known to be deficient in such cells. Our results suggest that hematopoietic/endothelial progenitors arise independently of Flk-1, but that their subsequent migration and expansion require a Flk-1-mediated signal.
Footnotes
-
↵ § These authors contributed equally to this work.
-
↵ ‖ To whom reprint requests should be addressed. e-mail: kchoi{at}pathology.wustl.edu.
- ABBREVIATIONS:
- VEGF,
- vascular endothelial growth factor;
- dpc,
- days postcoitum;
- ES,
- embryonic stem;
- BL-CFC,
- blast colony-forming cell;
- EB,
- embryoid body;
- LIF,
- leukemia inhibitory factor;
- EryP,
- primitive erythroid;
- RT-PCR,
- reverse transcription–PCR;
- FCS,
- fetal calf serum;
- FDG,
- fluorescein di-β-d-galactopyranoside;
- CDM,
- chemically defined medium;
- BMP-4,
- bone morphogenetic protein-4;
- KL,
- kit ligand;
- IL,
- interleukin;
- CSF,
- colony-stimulating factor;
- MTG,
- monothioglycerol
- Copyright © 1999, The National Academy of Sciences








